← Leaderboards
Michael J Betenbaugh
Johns Hopkins University
$3,385,463
Attributed
$4,135,462
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $500K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,635,463 · 3
FDA$1,499,999 · 1
By mechanism
R01$4,135,462 · 4
Top collaborators
- Caryn Heldt4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Gregory G Germino$9,875,396
- Ronald L Schnaar$20,308,382
- Kevin J Yarema$6,625,563
- Aravinda Chakravarti$56,493,374
- Elizabeth Hui Chen$13,327,744
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineGlycosylationPropertyMammalian CellGenerationsLipidsInterestProductionEngineeringProteinsBaseCrystallographyCellsCell SeparationCell Culture TechniquesAntibodiesDirected EvolutionBiotechnologyComplexApoptoticB-LymphocytesCrystallizationDna RepairAmino Acid Sequence
Grant awards (14)
Integrated and Continuous Manufacturing of an Influenza Vaccine$235,000
R01 · FY2024 · FD
Integrated and Continuous Manufacturing of an Influenza Vaccine$500,000
R01 · FY2023 · FD
Integrated and Continuous Manufacturing of an Influenza Vaccine$264,999
R01 · FY2022 · FD
Integrated and Continuous Manufacturing of an Influenza Vaccine$500,000
R01 · FY2021 · FD
Evolving membrane proteins for high-level expression in modified mammalian cells$288,090
R01 · FY2013 · GM · contact PI
Evolving membrane proteins for high-level expression in modified mammalian cells$297,000
R01 · FY2012 · GM · contact PI
Evolving membrane proteins for high-level expression in modified mammalian cells$297,000
R01 · FY2011 · GM · contact PI
Evolving membrane proteins for high-level expression in modified mammalian cells$300,000
R01 · FY2010 · GM · contact PI
Metabolic Engineering to Overcome N-Glycosylation Deficiency in Mammalian Cells$205,395
R01 · FY2008 · GM · contact PI
Metabolic Engineering to Overcome N-Glycosylation Deficiency in Mammalian Cells$205,902
R01 · FY2007 · GM · contact PI
Metabolic Engineering to Overcome N-Glycosylation Deficiency in Mammalian Cells$203,974
R01 · FY2006 · GM · contact PI
Engineering Sialylation Pathways in Insect Cells$277,522
R01 · FY2005 · GM
Engineering Sialylation Pathways in Insect Cells$274,600
R01 · FY2004 · GM
Engineering Sialylation Pathways in Insect Cells$285,980
R01 · FY2003 · GM